Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC) (ERIC)

This study has been terminated.
(Study terminated due to lack of resources.)
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Cardiovascular Institute of the South Clinical Research Corporation
ClinicalTrials.gov Identifier:
NCT01705509
First received: October 10, 2012
Last updated: April 5, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 31, 2017
  Primary Completion Date: March 31, 2017 (Final data collection date for primary outcome measure)